Balchem Corporation (BCPC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Total Cash From Operating Activities Chart for Balchem Corporation
Balchem Corporation (BCPC) operating cash flow for FY2025 was USD 216.6M, a 19.0% change from FY2024. Balchem Corporation's operating cash flow grew from USD 1.0M in 1989 to USD 216.6M in 2025 (21555.6% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of 7.5%, 10-year CAGR of 7.6%, 20-year CAGR of 14.8%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.64B
- Implied Share Price
- $177.00
- Enterprise Value
- $5.39B
- Revenue (TTM)
- $1.09B
- EBITDA
- $269.41M
- Profit Margin
- 15.14%
- Trailing P/E
- 34.84
- Forward P/E
- 29.33
- Price/Book (MRQ)
- 4.12
- Price/Sales (TTM)
- 5.20
- EV/EBITDA
- 20.34
- EV/Revenue
- 5.04
- Dividend Yield
- 0.55%
- Book Value
- $40.76
- Free Cash Flow (FY2025)
- $173.07M
- Free Cash Flow Yield
- 3.07%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.